Study shows false memories complicate end-of-life treatment decisions

False memories can play a significant role in the discrepancy between an individual’s true preferences for end-of-life treatment and what is instructed in their living will. Life-sustaining treatment preferences often change as people age or experience new health problems, and advance directive forms typically remind people of their right to update their directives if their wishes change. This assumes that people recognize when their wishes about end-of-life treatment have changed, and remember that their current wishes are different from those documented in their living will.

“Living wills are a noble idea and can often be very helpful in decisions that must be made near the end of life. But the notion that you can just fill out a document and all your troubles will be solved, a notion that is frequently reinforced in the popular media, is seriously misguided,” said Peter Ditto, professor of psychology and social behavior at UCI.

In research reported in the current issue of the American Psychological Association journal Health Psychology, a sample of 401 adults older than 65 were interviewed about which life-sustaining treatments they would want if they were seriously ill. They were interviewed again 12 months later to test their recall of earlier decisions. About one-third of participants changed their wishes regarding medical treatment such as CPR and “tube feeding” over the course of the year, and in 75 percent of these cases, participants falsely remembered that their original views on the issues matched their new ones.

Interviewers also talked to individuals empowered to make medical decisions if the study subjects were no longer able. These potential surrogate decision makers were even less sensitive to changes in their loved one’s wishes, showing false memories in 86 percent of cases.

“On a policy level, these results suggest that living wills should have an ‘expiration date.’ People can’t be counted upon to update their directives as their wishes change because they often have no awareness that their wishes have changed,” Ditto said. “On a more personal level, our research stresses the importance of maintaining an ongoing dialogue among individuals, their families and their physicians about end-of-life treatment options,” he continued.

The study was conducted by Ditto, Loftus, Maryanne Garry of Victoria University of Wellington, Jill A. Jacobson of Queen’s University and Stefanie J. Sharman of the University of New South Wales.

Source: University of California, Irvine

When should children with HIV infection be started on anti-HIV medications?
The advent of effective medications for treating HIV dramatically improved the outlook for both adults and children infected with HIV who had access to treatment, but the optimal timing for starting treatment remains controversial, particularly in children. A debate article in this week's PLoS Medicine lays out the case for deferred treatment against the case for early initiation of treatment in children infected with HIV.
New UIC center to study end-of-life transition
The University of Illinois at Chicago College of Nursing has received a federal grant to create a center to study people as they transition to the end of life.
Research probes seniors' plans for end-of-life care
As a brain-damaged woman named Terri Schiavo lived her final days in 2005, her family's bitter feuding imparted a tragic lesson about the importance of specifying one's wishes for end-of-life medical treatment.
25 years of conventional evaluation of data analysis proves worthless in practice
So-called 'intelligent' computer-based methods for classifying patient samples, for example, have been evaluated with the help of two methods that have completely dominated research for 25 years. Now Swedish researchers at Uppsala University are revealing that this methodology is worthless when it comes to practical problems. The article is published in the journal Pattern Recognition Letters.
When the patient can't decide
Family members are often called upon to make medical choices for patients who are unable to do so themselves. Researchers led by Alexia Torke, M.D., of the Indiana University School of Medicine and the Regenstrief Institute, Inc., studied how physicians treating these patients interacted with surrogate decision-makers.
Bluffing could be common in prediction markets, study shows
A new mathematical model by researchers at the University of Michigan suggests that bluffing in prediction markets is a profitable strategy more often than previously thought.
Researchers demonstrate for the first time how light squeezes through small holes
How does light pass through a tiny hole" For the first time, Dr Aurele Adam and Prof. Paul Planken of Delft University of Technology, in conjunction with two South Korean and one German research groups, have succeeded in mapping this process properly.
Vitamin D in brain function
In a definitive critical review, scientists at Children’s Hospital & Research Center Oakland ask whether there is convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction. Joyce C. McCann, Ph.D., assistant staff scientist and Bruce N. Ames, Ph.D., senior scientist at Children’s Hospital Oakland Research Institute (CHORI) conclude that there is ample biological evidence to suggest an important role for vitamin D in brain development and function, and that supplementation for groups chronically low in vitamin D is warranted. Their conclusions will be published on April 22, 2008 in the Federation of American Societies for Experimental Biology (FASEB) Journal.

Study shows false memories complicate end-of-life treatment decisions

Related stories:

News discussion: